Publication | Closed Access
High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system
73
Citations
13
References
2013
Year
Neuro-oncologyMedicinePathologyNeurologyCentral Nervous SystemNeuropathologyPharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1